Top Markets
Coin of the day
Medtronic plc Medtronic plc

Medtronic plc

2M6
Rangering i aksjer #164
Medtronic plc develops, manufactures, and sells device-based medical therapies... Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.
Aksjekurs
$88.89
Markedsverdi
$114.13B
Endring (1 dag)
-0.93%
Endring (1 år)
-2.08%
Land
IE
Handel Medtronic plc (2M6)

Kategori

P/E-forhold for Medtronic plc (2M6)
P/E-forhold per March 2026 TTM: 24.21
Ifølge Medtronic plc sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/E-forhold (TTM) 24.21. Ved slutten av 2024 hadde selskapet en P/E på 28.98.
P/E-forholdshistorikk for Medtronic plc fra 2000 til 2026
P/E-forhold ved slutten av hvert år
År P/E-forhold Endre
2026 (TTM) 24.21 3.61%
2025 23.37 -19.35%
2024 28.98 -9.95%
2023 32.18 15.76%
2022 27.80 -43.06%
2021 48.83 75.64%
2020 27.80 9.46%
2019 25.40 -28.52%
2018 35.53 24.91%
2017 28.44 -9.80%
2016 31.53 -0.78%
2015 31.78 65.27%
2014 19.23 40.13%
2013 13.72 23.30%
2012 11.13 -23.39%
2011 14.53 -6.85%
2010 15.60 -5.77%
2009 16.55 -32.91%
2008 24.67 13.60%
2007 21.72 -8.07%
2006 23.62 -33.21%
2005 35.37 13.16%
2004 31.26 -13.97%
2003 36.33 -33.97%
2002 55.03 7.28%
2001 51.29 -9.73%
2000 56.83 0.00%
P/E-forhold for lignende selskaper eller konkurrenter
Selskap P/E-forhold Forskjell i P/E-forhold Land
28.93 19.47%
US
39.68 63.89%
US
24.21 0.00%
IE
35.47 46.47%
US
20.43 -15.63%
DE
Hvordan lese en P/E-ratio?

Pris/inntjening-forholdet (P/E) måler forholdet mellom aksjekursen og inntjening per aksje.
En lav men positiv P/E indikerer høy inntjening sammenlignet med nåværende verdsettelse, og kan tyde på at selskapet er undervurdert. En høy negativ (nær 0) P/E indikerer store tap.

Selskaper med P/E over 30 eller negativ betraktes vanligvis som "vekstaksjer", hvor investorer forventer vekst eller fremtidig lønnsomhet.

Selskaper med en positiv P/E under 10 anses vanligvis som "verdiaksjer", det vil si at selskapet allerede er lønnsomt, men har begrenset vekstpotensial.